GlaxoSmithKline Plc reported sales of £5.6 billion for the first quarter, unchanged from a year earlier, and an operating profit of £1.3 billion, down by 15% as the group rebalanced its business with a greater focus on consumer healthcare. ---Subscribe to MedNous to access this article--- Company News
